BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8319221)

  • 1. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
    Smaaland R; Lote K; Sothern RB; Laerum OD
    Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
    De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
    Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
    Joensuu H; Klemi PJ; Eerola E
    J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circadian rhythms of DNA synthesis and apoptosis correlated gene expression in bone marrow cells of nude mice bearing human nasopharyngeal carcinoma].
    Sun J; Xian LJ; Cao QY; Ye YL; Zeng ZL; Liu XH; Li XM; Levi F
    Ai Zheng; 2002 Aug; 21(8):833-7. PubMed ID: 12478887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular DNA of human neoplastic B-cells measured by flow cytometry.
    Braylan RC; Benson NA; Nourse VA
    Cancer Res; 1984 Nov; 44(11):5010-6. PubMed ID: 6435862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA--ploidy in non hodgkin's lymphomas of low malignancy].
    Krygier-Stojałowska A; Urasiński I; Kuchnio M; Gapski Z
    Acta Haematol Pol; 1993; 24(2):153-60. PubMed ID: 8372615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival of patients and DNA-ploidy of cells in non-Hodgkin's lymphoma of low-grade malignancy].
    Urasiński I; Urasiński T; Krygier-Stojałowska A
    Acta Haematol Pol; 1994; 25(4):355-61. PubMed ID: 7847037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
    Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
    Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
    Pituch-Noworolska A; Gawlicka M
    Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.